DosisPedia

65
DosisPedia
DosisPedia is an Android app from DosisPedia in the Medical category, currently rated 4.7★ across 3,671 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 65: Solid (established niche player). For a Medical app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 💎 In-app purchase plumbing | +$9K |
| ⚙ Medical complexity ×1.55 | +$32K |
| 🌐 Cross-platform reach (iOS + Android) | +$50K |
Synthetic estimate. Multiple band derived from iap / freemium model + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 💎 IAP / freemium model base | 28× MRR |
| ⭐ ★ rating ≥ 4.7 (premium) | +15% |
| 🏷 Medical category multiple | +12% |
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
| 📲 Medical engagement | ~55 installs / rating |
| 🔁 Medical D30 retention | 25% |
| 📍 DAU / MAU stickiness | 0.20 |
How we forecast this revenue
MEDIUM CONFIDENCEBU Investment Matrix
Below median · 54/100MID TIERunderperforming peers- 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.74★ across 3,671 reviews — strong (top 10%).
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL| Excellent rating (4.7★)METRIC | +$2,200 | |
| Low install base (3,671 ratings)METRIC | +$1,500 | |
| Mature app (11y old)METRIC | +$1,500 | |
| Ad-supported / freemiumMETRIC | +$600 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- DosisPedia
- Developer
- DosisPedia
- Bundle ID
- com.smartgalapps.android.medicine.dosispedia.app
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- dosispedia.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $751/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- $0.99 - $3.49 per item
Founder
Funding
Press & Links
Contacts & Socials
📈Ratings growth3,671 ratings+27% lifetimeShow 3-year history estimate ▾
📝 About this app
DosisPedia helps in the day to day more than 600,000 professionals solving more than 32 million queries.
1º SELECT THE DRUG GROUP
DosisPedia is a pharmacological guide that allows the doctor to quickly consult the drug and define the prescription. To start, choose the group of drugs you want information about.
2nd SELECT THE DRUG
You can select one of the medications and you can also write the name of the drug or active ingredient in the search engine.
3º CONSULTATION THE INDICATION FOR EACH WEIGHT… View full description on the official store →
Track this app’s revenue
FREE📝 Description
95
Why medium confidence: 3,671 ratings · no founder-verified revenue (model estimate only).




